Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Sponsor: Novartis Pharmaceuticals
Summary
A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
Official title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of LTP001 in Healthy Adult Participants (Part A) and to Evaluate the Efficacy and Safety of LTP001 for the Treatment of Participants With Pulmonary Arterial Hypertension (Part B)
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
232
Start Date
2024-10-24
Completion Date
2028-12-31
Last Updated
2026-04-29
Healthy Volunteers
Yes
Interventions
LTP
LTP001
Placebo
Placebo
Locations (85)
Arizona Pulmonary Specialists Ltd
Scottsdale, Arizona, United States
UC Irvine Medical Center
Orange, California, United States
Stanford Medical Center
Stanford, California, United States
Univ Colorado Hospital
Aurora, Colorado, United States
Central Florida Pulmonary Group
Orlando, Florida, United States
University of South Florida
Tampa, Florida, United States
Emory University School of Medicine
Atlanta, Georgia, United States
U of Kansas Medical Center
Kansas City, Kansas, United States
Norton Infectious Diseases Specialists
Louisville, Kentucky, United States
Tufts Medical Center
Boston, Massachusetts, United States
Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
Sky Integrative Medical Center SKYCRNG PPDS
Ridgeland, Mississippi, United States
Summit Health Eastside Clinic
Bend, Oregon, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Statcare Pulmonary Consultants
Knoxville, Tennessee, United States
PPD Development LP
Austin, Texas, United States
UT Southwestern Medical Center
Dallas, Texas, United States
The University of Utah
Salt Lake City, Utah, United States
Pul Ass Richmond Inc P A R
Richmond, Virginia, United States
Novartis Investigative Site
Buenos Aires, Buenos Aires F.D., Argentina
Novartis Investigative Site
CABA, Argentina
Novartis Investigative Site
Río Cuarto, Argentina
Novartis Investigative Site
San Miguel de Tucumán, Argentina
Novartis Investigative Site
Santa Fe, Argentina
Novartis Investigative Site
Camperdown, New South Wales, Australia
Novartis Investigative Site
Darlinghurst, New South Wales, Australia
Novartis Investigative Site
New Lambton Heights, New South Wales, Australia
Novartis Investigative Site
Adelaide, South Australia, Australia
Novartis Investigative Site
Leuven, Vlaams Brabant, Belgium
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, Brazil
Novartis Investigative Site
Prague, Czechia
Novartis Investigative Site
Prague, Czechia
Novartis Investigative Site
Angers, France, France
Novartis Investigative Site
Brest, France
Novartis Investigative Site
Clamart, France
Novartis Investigative Site
Grenoble, France
Novartis Investigative Site
Montpellier, France
Novartis Investigative Site
Nice, France
Novartis Investigative Site
Pessac, France
Novartis Investigative Site
Poitiers, France
Novartis Investigative Site
Saint-Priest-en-Jarez, France
Novartis Investigative Site
Strasbourg, France
Novartis Investigative Site
Toulouse, France
Novartis Investigative Site
Vandœuvre-lès-Nancy, France
Novartis Investigative Site
Regensburg, Bavaria, Germany
Novartis Investigative Site
Dresden, Saxony, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Giessen, Germany
Novartis Investigative Site
Greifswald, Germany
Novartis Investigative Site
Heidelberg, Germany
Novartis Investigative Site
Homburg, Germany
Novartis Investigative Site
Athens, Greece
Novartis Investigative Site
Chaïdári, Greece
Novartis Investigative Site
Thessaloniki, Greece
Novartis Investigative Site
Foggia, FG, Italy
Novartis Investigative Site
Monza, MB, Italy
Novartis Investigative Site
Palermo, PA, Italy
Novartis Investigative Site
Pavia, PV, Italy
Novartis Investigative Site
Roma, RM, Italy
Novartis Investigative Site
Sassari, SS, Italy
Novartis Investigative Site
Ivrea, TO, Italy
Novartis Investigative Site
Trieste, TS, Italy
Novartis Investigative Site
Riga, Latvia
Novartis Investigative Site
Monterrey, Nuevo León, Mexico
Novartis Investigative Site
San Luis Potosí City, San Luis Potosí, Mexico
Novartis Investigative Site
Poznan, Poland
Novartis Investigative Site
Almada, Portugal
Novartis Investigative Site
Lisbon, Portugal
Novartis Investigative Site
Timișoara, Timiș County, Romania
Novartis Investigative Site
Bucharest, Romania
Novartis Investigative Site
Belgrade, Serbia, Serbia
Novartis Investigative Site
Kamenitz, Serbia
Novartis Investigative Site
Niš, Serbia
Novartis Investigative Site
Santiago Compostela, A Coruna, Spain
Novartis Investigative Site
Marbella, Andalusia, Spain
Novartis Investigative Site
Toledo, Castille-La Mancha, Spain
Novartis Investigative Site
Barcelona, Catalonia, Spain
Novartis Investigative Site
Las Palmas de Gran C, Las Palmas, Spain
Novartis Investigative Site
Barcelona, Spain
Novartis Investigative Site
Seville, Spain
Novartis Investigative Site
Sheffield, South Yorkshire, United Kingdom
Novartis Investigative Site
Cambridge, United Kingdom
Novartis Investigative Site
London, United Kingdom
Novartis Investigative Site
London, United Kingdom